Stocks
Beyond new surge of meme stocks, one of the most widely discussed news of the past week came in the form of approval for Biogen’s (BIIB) Alzheimer's drug Aduhelm. The approval polarized both the scientific and stock trading community. The stock, which on the day of the approval at one point peaked at about 64% gain, ended the week up about 40%.
June 14, 2021
3506
Popular posts
Stocks
Alibaba’s Earnings vs. China’s Regulatory Actions: Waiting for Stock Reentry Signals
August 4, 2021
4030
Cryptocurrencies
Ethereum “London” Change of Protocol: Big Deal or Much Ado About Nothing?
August 6, 2021
4025
Cryptocurrencies
show more
Why Robinhood IPO is Highly Contingent on Crypto Market Performance
July 2, 2021
3977